Skip to content

Tyra Biosciences, Inc. TYRA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$131.11M-9.3%-$119.95M-7.4%-$111.68M-5.5%-$105.83M-9.7%-$96.44M-11.5%
$541K-0.9%$546K-2.2%$558K+0.7%$554K+2.6%$540K+4.0%
$29.43M+5.1%$28.01M+3.4%$27.08M0.0%$27.08M+7.8%$25.11M+10.1%
-$102.26M-7.5%-$95.14M-4.4%-$91.11M-5.2%-$86.63M-18.3%-$73.2M-4.9%
$215K+52.5%$141K+56.7%$90K-12.6%$103K-81.0%$542K-18.4%
$166.3M+1,953%$8.1M+96.5%$4.12M-2.3%$4.22M+5.2%$4.01M-98.0%
-$102.47M-7.5%-$95.28M-4.5%-$91.2M-5.2%-$86.73M-17.6%-$73.75M-4.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Tyra Biosciences, Inc. generate?
Tyra Biosciences, Inc. (TYRA) generated -$102.3M in operating cash flow over the trailing twelve months.
What is Tyra Biosciences, Inc.'s free cash flow?
After $215.0K of capital expenditures, Tyra Biosciences, Inc.'s free cash flow was -$102.5M over the trailing twelve months, down 39.0% year over year.
Where does Tyra Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.